Vir Biotechnology, Inc. VIR Other revenue — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s other revenue — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s other revenue — total revenues?
- Vir Biotechnology, Inc. (VIR) reported other revenue — total revenues of $0 in Q1 2026.
- How has Vir Biotechnology, Inc.'s other revenue — total revenues changed year-over-year?
- Vir Biotechnology, Inc.'s other revenue — total revenues decreased by 100.0% year-over-year, from $1.86M to $0.
- What does other revenue — total revenues mean?
- This metric represents the total revenue generated from secondary business activities or non-core product lines that fall outside the company's primary therapeutic focus areas. It captures income streams such as ancillary service contracts, licensing fees, or miscellaneous commercial activities that contribute to the company's overall top-line performance. Monitoring this segment helps investors assess the diversification of revenue sources beyond the core clinical pipeline.